RIGOLIN, Gian Matteo
RIGOLIN, Gian Matteo
Dipartimento di Scienze mediche
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features
file con accesso da definire1999 Cuneo, Antonio; Bigoni, Renato; Rigolin, Gian Matteo; Roberti, Maria Grazia; Bardi, A; Campioni, Diana; Minotto, C; Agostini, Paola; Milani, R; Bullrich, F; Negrini, Massimo; Croce, Carlo Maria; Castoldi, Gianluigi
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study.
file con accesso da definire1998 Bigoni, R.; Cuneo, Antonio; Roberti, M. G.; Bardi, A.; Rigolin, Gian Matteo; Campioni, Diana; Pedriali, L.; Piva, N.; Bullrich, F.; Croce, Carlo Maria; Castoldi, Gl
A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin.
file con accesso da definire2005 Fraulini, Chiara; Mauro, Endri; Rigolin, Gian Matteo; Bissoli, S.; Chierichetti, F.; Panareo, Stefano; Feggi, Luciano; Cavazzini, Luigi; Castoldi, Gianluigi
A case of disseminated Langerhans' cell histiocytosis treated with thalidomide
file con accesso da definire2005 Mauro, Endri; Fraulini, Chiara; Rigolin, Gian Matteo; Galeotti, Roberto; Spanedda, Romedio; Castoldi, Gianluigi
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia.
file con accesso da definire2005 Cavazzini, Francesco; Cuneo, Antonio; Bardi, A.; Tammiso, Elisa; Agostini, Paola; Ciccone, Maria; RUSSO ROSSI, Antonella; Dabusti, Melissa; Tiseo, Ruana; Rigolin, Gian Matteo; Castoldi, Gianluigi
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia.
file con accesso da definire2005 Cavazzini, Francesco; Cuneo, Antonio; Bardi, A.; Tammiso, Elisa; Agostini, Paola; Ciccone, Maria; Dabusti, Melissa; Rigolin, Gian Matteo; Castoldi, Gianluigi
A Molecular Model to Predict Durable Remission after First Line Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia
file con accesso da definire2014 Rossi, D; di Bergamo, Lt; Chiarenza, A; Bulian, P; Visco, C; Mauro, Fr; Morabito, F; Cortelezzi, A; Zaja, F; Forconi, F; Laurenti, L; Del Giudice, I; De Paoli, L; Vincelli, I; Rigolin, Gian Matteo; Marasca, R; Perbellini, O; Moreno, C; Del Poeta, G; Massaia, M; Zinzani, Pl; Montillo, M; Cuneo, Antonio; Foa, R; Gattei, V; Gaidano, G.
A PHASE II STUDY EXPLORING THE FEASIBILITY OF AZACITIDINE AND LENALIDOMIDE USE (COMBINATION vs SEQUENTIAL TREATMENT) FOR HIGHER-RISK MYELODYSPLASTIC SYNDROMES (IPSS RISK: HIGH OR INT-2)
file con accesso da definire2014 Finelli, C; Clissa, C; Follo, My; Stanzani, M; Avanzini, P; Bosi, C; Castagnari, B; Candoni, A; Crugnola, M; Giannini, Mb; Gobbi, M; Leonardi, G; Rigolin, Gian Matteo; Russo, D; Tosi, P; Visani, G; Farnedi, A; Cavo, M.
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients
file con accesso da definire2011 Maffei, R.; Martinelli, S.; Debbia, G.; Rigolin, Gian Matteo; Rizzotto, Lara; Castelli, I.; Bonacorsi, G.; Bulgarelli, J; Fiorcari, S.; Zucchini, P.; Santachiara, R.; Forconi, F.; Rossi, D.; Laurenti, L.; Palumbo, G. A.; Vallisa, D.; Cuneo, Antonio; Gaidano, G.; Luppi, M.; Marasca, R.
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes
file con accesso da definire1998 Ferrini, P. R.; Grossi, A.; Vannucchi, A. M.; Barosi, G.; Guarnone, R.; Piva, N.; Musto, P.; Balleari, E; Investigator, ; Castoldi, Gianluigi; Piva, N; Rigolin, Gian Matteo; Rossi, P. F.; Grossi, A; Vannucchi, A. M.; Fabbri, A; Leoni, F; Ghio, R; Balleari, E; Maiolo, A. T.; Cortelezzi, A; Calori, R; Morra, E; Cairoli, R; Gabbas, A; Cicalo, F; Rizzoli, V; Caramatti, C; Bernasconi, C; Bonfichi, M; Ascari, E; Barosi, G; Guarnone, R; Carotenuto, M; Musto, P; Resegotti, L; Degani, G; Perona, G; Nadali, G.
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia
2019 Visentin, A.; Deodato, M.; Mauro, F. R.; Autore, F.; Reda, G.; Vitale, C.; Molica, S.; Rigolin, G. M.; Piazza, F.; Cesini, L.; Tedeschi, A.; Laurenti, L.; Cassin, R.; Coscia, M.; Cuneo, A.; Foa, R.; Semenzato, G.; Trentin, L.
A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results
2020 Sessa, Mariarosaria; Cavazzini, Francesco; Cavallari, Maurizio; Rigolin, Gian Matteo; Cuneo, Antonio
Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11-32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia
file con accesso da definire2004 Cavazzini, Francesco; Cuneo, Antonio; DE ANGELI, Cristiano; Bardi, A.; Agostini, Paola; Tammiso, Elisa; Rigolin, Gian Matteo; Castoldi, Gianluigi
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features
file con accesso da definire2000 Cuneo, Antonio; Bigoni, R; Rigolin, Gian Matteo; Roberti, Mg; Milani, R; Bardi, A; Minotto, C; Agostini, P; DE ANGELI, C; Narducci, Mg; Sabbioni, Silvia; Russo, G; Negrini, Massimo; Castoldi, Gianluigi
Addition of Lenalidomide (LEN) to Azacitidine (AZA) (Combined vs Sequential Treatment) in High-Risk Myelodysplastic Syndromes (MDS): A Randomized Phase II Multicenter Study
file con accesso da definire2014 Finelli, C; Clissa, C; Follo, My; Stanzani, M; Avanzini, P; Bosi, C; Castagnari, B; Candoni, A; Crugnola, M; Giannini, Mb; Gobbi, M; Leonardi, G; Rigolin, Gian Matteo; Tosi, P; Visani, G; Cocco, L; Cavo, M; Russo, D.
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low-risk chronic lymphocytic leukaemia patients
file con accesso da definire2023 Rigolin, Gian Matteo; Traversa, Alice; Caputo, Viviana; Del Giudice, Ilaria; Bardi, Antonella; Saccenti, Elena; Raponi, Sara; Ilari, Caterina; Cafforio, Luciana; Giovannetti, Agnese; Pizzuti, Antonio; Guarini, Anna; Foà, Robin; Cuneo, Antonio
Alterazioni cromosomiche in cellule staminali emopoietiche indotte da esposizioni ambientali o professionali.
file con accesso da definire2001 Cuneo, Antonio; Rigolin, Gian Matteo; Agostini, Paola; Roberti, Maria Grazia; Bardi, A; Tammiso, Elisa; Cavazzini, Francesco; Tieghi, A; Bigoni, R; Castoldi, Gianluigi
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness
file con accesso da definire2017 Rigolin, Gian Matteo; Formigaro, Luca; Cavallari, Maurizio; Quaglia, Francesca Maria; Lista, Enrico; Urso, Antonio; Guardalben, Emanuele; Martinelli, Sara; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, Aurora; Negrini, Massimo; Cavazzini, Francesco; Cuneo, Antonio
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness
file con accesso da definire2017 Rigolin, Gian Matteo; Formigaro, Luca; Cavallari, Maurizio; Quaglia, Francesca Maria; Lista, E; Urso, Antonio; Guardalben, Emanuele; Martinelli, Sara; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, A; Negrini, Massimo; Cavazzini, Francesco; Cuneo, Antonio
An unusual case of untreated chronic lymphocytic leukemia patient presenting with Rhodococcus equi bacteriemia [10]
file con accesso da definire1996 Rigolin, Gian Matteo; Bigoni, Renato; Spanedda, Romedio; Castoldi, Gianluigi; Rossi, Maria Rita
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features | 1999 | Cuneo, Antonio; Bigoni, Renato; Rigolin, Gian Matteo; Roberti, Maria Grazia; Bardi, A; Campioni, ...Diana; Minotto, C; Agostini, Paola; Milani, R; Bullrich, F; Negrini, Massimo; Croce, Carlo Maria; Castoldi, Gianluigi | file con accesso da definire |
| 13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. | 1998 | Bigoni, R.; Cuneo, Antonio; Roberti, M. G.; Bardi, A.; Rigolin, Gian Matteo; Campioni, Diana; Ped...riali, L.; Piva, N.; Bullrich, F.; Croce, Carlo Maria; Castoldi, Gl | file con accesso da definire |
| A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin. | 2005 | Fraulini, Chiara; Mauro, Endri; Rigolin, Gian Matteo; Bissoli, S.; Chierichetti, F.; Panareo, Ste...fano; Feggi, Luciano; Cavazzini, Luigi; Castoldi, Gianluigi | file con accesso da definire |
| A case of disseminated Langerhans' cell histiocytosis treated with thalidomide | 2005 | Mauro, Endri; Fraulini, Chiara; Rigolin, Gian Matteo; Galeotti, Roberto; Spanedda, Romedio; Casto...ldi, Gianluigi | file con accesso da definire |
| A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. | 2005 | Cavazzini, Francesco; Cuneo, Antonio; Bardi, A.; Tammiso, Elisa; Agostini, Paola; Ciccone, Maria;... RUSSO ROSSI, Antonella; Dabusti, Melissa; Tiseo, Ruana; Rigolin, Gian Matteo; Castoldi, Gianluigi | file con accesso da definire |
| A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. | 2005 | Cavazzini, Francesco; Cuneo, Antonio; Bardi, A.; Tammiso, Elisa; Agostini, Paola; Ciccone, Maria;... Dabusti, Melissa; Rigolin, Gian Matteo; Castoldi, Gianluigi | file con accesso da definire |
| A Molecular Model to Predict Durable Remission after First Line Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia | 2014 | Rossi, D; di Bergamo, Lt; Chiarenza, A; Bulian, P; Visco, C; Mauro, Fr; Morabito, F; Cortelezzi, ...A; Zaja, F; Forconi, F; Laurenti, L; Del Giudice, I; De Paoli, L; Vincelli, I; Rigolin, Gian Matteo; Marasca, R; Perbellini, O; Moreno, C; Del Poeta, G; Massaia, M; Zinzani, Pl; Montillo, M; Cuneo, Antonio; Foa, R; Gattei, V; Gaidano, G. | file con accesso da definire |
| A PHASE II STUDY EXPLORING THE FEASIBILITY OF AZACITIDINE AND LENALIDOMIDE USE (COMBINATION vs SEQUENTIAL TREATMENT) FOR HIGHER-RISK MYELODYSPLASTIC SYNDROMES (IPSS RISK: HIGH OR INT-2) | 2014 | Finelli, C; Clissa, C; Follo, My; Stanzani, M; Avanzini, P; Bosi, C; Castagnari, B; Candoni, A; C...rugnola, M; Giannini, Mb; Gobbi, M; Leonardi, G; Rigolin, Gian Matteo; Russo, D; Tosi, P; Visani, G; Farnedi, A; Cavo, M. | file con accesso da definire |
| A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients | 2011 | Maffei, R.; Martinelli, S.; Debbia, G.; Rigolin, Gian Matteo; Rizzotto, Lara; Castelli, I.; Bonac...orsi, G.; Bulgarelli, J; Fiorcari, S.; Zucchini, P.; Santachiara, R.; Forconi, F.; Rossi, D.; Laurenti, L.; Palumbo, G. A.; Vallisa, D.; Cuneo, Antonio; Gaidano, G.; Luppi, M.; Marasca, R. | file con accesso da definire |
| A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes | 1998 | Ferrini, P. R.; Grossi, A.; Vannucchi, A. M.; Barosi, G.; Guarnone, R.; Piva, N.; Musto, P.; Ball...eari, E; Investigator, ; Castoldi, Gianluigi; Piva, N; Rigolin, Gian Matteo; Rossi, P. F.; Grossi, A; Vannucchi, A. M.; Fabbri, A; Leoni, F; Ghio, R; Balleari, E; Maiolo, A. T.; Cortelezzi, A; Calori, R; Morra, E; Cairoli, R; Gabbas, A; Cicalo, F; Rizzoli, V; Caramatti, C; Bernasconi, C; Bonfichi, M; Ascari, E; Barosi, G; Guarnone, R; Carotenuto, M; Musto, P; Resegotti, L; Degani, G; Perona, G; Nadali, G. | file con accesso da definire |
| A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia | 2019 | Visentin, A.; Deodato, M.; Mauro, F. R.; Autore, F.; Reda, G.; Vitale, C.; Molica, S.; Rigolin, G.... M.; Piazza, F.; Cesini, L.; Tedeschi, A.; Laurenti, L.; Cassin, R.; Coscia, M.; Cuneo, A.; Foa, R.; Semenzato, G.; Trentin, L. | |
| A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results | 2020 | Sessa, Mariarosaria; Cavazzini, Francesco; Cavallari, Maurizio; Rigolin, Gian Matteo; Cuneo, Antonio | |
| Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11-32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia | 2004 | Cavazzini, Francesco; Cuneo, Antonio; DE ANGELI, Cristiano; Bardi, A.; Agostini, Paola; Tammiso, ...Elisa; Rigolin, Gian Matteo; Castoldi, Gianluigi | file con accesso da definire |
| Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features | 2000 | Cuneo, Antonio; Bigoni, R; Rigolin, Gian Matteo; Roberti, Mg; Milani, R; Bardi, A; Minotto, C; Ag...ostini, P; DE ANGELI, C; Narducci, Mg; Sabbioni, Silvia; Russo, G; Negrini, Massimo; Castoldi, Gianluigi | file con accesso da definire |
| Addition of Lenalidomide (LEN) to Azacitidine (AZA) (Combined vs Sequential Treatment) in High-Risk Myelodysplastic Syndromes (MDS): A Randomized Phase II Multicenter Study | 2014 | Finelli, C; Clissa, C; Follo, My; Stanzani, M; Avanzini, P; Bosi, C; Castagnari, B; Candoni, A; C...rugnola, M; Giannini, Mb; Gobbi, M; Leonardi, G; Rigolin, Gian Matteo; Tosi, P; Visani, G; Cocco, L; Cavo, M; Russo, D. | file con accesso da definire |
| Additional lesions identified by genomic microarrays are associated with an inferior outcome in low-risk chronic lymphocytic leukaemia patients | 2023 | Rigolin, Gian Matteo; Traversa, Alice; Caputo, Viviana; Del Giudice, Ilaria; Bardi, Antonella; Sa...ccenti, Elena; Raponi, Sara; Ilari, Caterina; Cafforio, Luciana; Giovannetti, Agnese; Pizzuti, Antonio; Guarini, Anna; Foà, Robin; Cuneo, Antonio | file con accesso da definire |
| Alterazioni cromosomiche in cellule staminali emopoietiche indotte da esposizioni ambientali o professionali. | 2001 | Cuneo, Antonio; Rigolin, Gian Matteo; Agostini, Paola; Roberti, Maria Grazia; Bardi, A; Tammiso, ...Elisa; Cavazzini, Francesco; Tieghi, A; Bigoni, R; Castoldi, Gianluigi | file con accesso da definire |
| An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness | 2017 | Rigolin, Gian Matteo; Formigaro, Luca; Cavallari, Maurizio; Quaglia, Francesca Maria; Lista, Enri...co; Urso, Antonio; Guardalben, Emanuele; Martinelli, Sara; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, Aurora; Negrini, Massimo; Cavazzini, Francesco; Cuneo, Antonio | file con accesso da definire |
| An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness | 2017 | Rigolin, Gian Matteo; Formigaro, Luca; Cavallari, Maurizio; Quaglia, Francesca Maria; Lista, E; U...rso, Antonio; Guardalben, Emanuele; Martinelli, Sara; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, A; Negrini, Massimo; Cavazzini, Francesco; Cuneo, Antonio | file con accesso da definire |
| An unusual case of untreated chronic lymphocytic leukemia patient presenting with Rhodococcus equi bacteriemia [10] | 1996 | Rigolin, Gian Matteo; Bigoni, Renato; Spanedda, Romedio; Castoldi, Gianluigi; Rossi, Maria Rita | file con accesso da definire |